S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study

Sarah Harris; Brian G. Feagan; Stephen B. Hanauer; Séverine Vermeire; Subrata Ghosh; Jim Yan; Chun Wu; Yanhua Hu; Rachel Maddux; Douglas C. Wolf; Geert R. D’Haens

doi:10.14309/01.ajg.0000954176.61528.15

S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study

Sarah Harris
, Brian G. Feagan
, Stephen B. Hanauer
, Séverine Vermeire
, Subrata Ghosh
, Jim Yan
, Chun Wu
, Yanhua Hu
, Rachel Maddux
, Douglas C. Wolf
, Geert R. D’Haens

Bristol-Myers Squibb
Western University
Northwestern University
Universitair Ziekenhuis Leuven
Laboratory Corporation of America
Atlanta Gastroenterology Associates
Amsterdam University Medical Centers

Research output: Contribution to journal › Article › peer-review

Original language	English (Ireland)
Pages (from-to)	S867-S868
Journal	American Journal of Gastroenterology
Volume	118
Issue number	10S
DOIs	https://doi.org/10.14309/01.ajg.0000954176.61528.15
Publication status	Published - Oct 2023

Access to Document

10.14309/01.ajg.0000954176.61528.15

Cite this

Harris, S., Feagan, B. G., Hanauer, S. B., Vermeire, S., Ghosh, S., Yan, J., Wu, C., Hu, Y., Maddux, R., Wolf, D. C., & D’Haens, G. R. (2023). S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study. American Journal of Gastroenterology, 118(10S), S867-S868. https://doi.org/10.14309/01.ajg.0000954176.61528.15

@article{ccc8f14da8ee4cb3b92c7537d559077b,

title = "S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn{\textquoteright}s Disease (CD): Results From the Phase 2 STEPSTONE Study",

author = "Sarah Harris and Feagan, \{Brian G.\} and Hanauer, \{Stephen B.\} and S{\'e}verine Vermeire and Subrata Ghosh and Jim Yan and Chun Wu and Yanhua Hu and Rachel Maddux and Wolf, \{Douglas C.\} and D{\textquoteright}Haens, \{Geert R.\}",

year = "2023",

month = oct,

doi = "10.14309/01.ajg.0000954176.61528.15",

language = "English (Ireland)",

volume = "118",

pages = "S867--S868",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "10S",

}

Harris, S, Feagan, BG, Hanauer, SB, Vermeire, S, Ghosh, S, Yan, J, Wu, C, Hu, Y, Maddux, R, Wolf, DC & D’Haens, GR 2023, 'S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study', American Journal of Gastroenterology, vol. 118, no. 10S, pp. S867-S868. https://doi.org/10.14309/01.ajg.0000954176.61528.15

S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study. / Harris, Sarah; Feagan, Brian G.; Hanauer, Stephen B. et al.
In: American Journal of Gastroenterology, Vol. 118, No. 10S, 10.2023, p. S867-S868.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study

AU - Harris, Sarah

AU - Feagan, Brian G.

AU - Hanauer, Stephen B.

AU - Vermeire, Séverine

AU - Ghosh, Subrata

AU - Yan, Jim

AU - Wu, Chun

AU - Hu, Yanhua

AU - Maddux, Rachel

AU - Wolf, Douglas C.

AU - D’Haens, Geert R.

PY - 2023/10

Y1 - 2023/10

UR - https://www.mendeley.com/catalogue/8e5e4dec-190c-3afb-bbc5-4f2aa28e46a3/

U2 - 10.14309/01.ajg.0000954176.61528.15

DO - 10.14309/01.ajg.0000954176.61528.15

M3 - Article

SN - 0002-9270

VL - 118

SP - S867-S868

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 10S

ER -

Harris S, Feagan BG, Hanauer SB, Vermeire S, Ghosh S, Yan J et al. S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study. American Journal of Gastroenterology. 2023 Oct;118(10S):S867-S868. doi: 10.14309/01.ajg.0000954176.61528.15

S1134 Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn’s Disease (CD): Results From the Phase 2 STEPSTONE Study

Access to Document

Other files and links

Cite this